title: Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.
abstract: The kinetics of respiratory syncytial virus (RSV) neutralizing antibodies following birth, primary and secondary infections are poorly defined. The aims of the study were to measure and compare neutralizing antibody responses at different time points in a birth cohort followed-up over three RSV epidemics. Rural Kenyan children, recruited at birth between 2002 and 2003, were monitored for RSV infection over three epidemic seasons. Cord and 3-monthly sera, and acute and convalescent sera following RSV infection, were assayed in 28 children by plaque reduction neutralization test (PRNT). Relative to the neutralizing antibody titers of pre-exposure control sera (1.8 log10 PRNT), antibody titers following primary infection were (i) no different in sera collected between 0 and 0.4 months post-infection (1.9 log10 PRNT, P=0.146), (ii) higher in sera collected between 0.5 and 0.9 (2.8 log10 PRNT, P<0.0001), 1.0-1.9 (2.5 log10 PRNT, P<0.0001), and 2.0-2.9 (2.3 log10 PRNT, P<0.001) months post-infection, and (iii) no different in sera collected at between 3.0 and 3.9 months post-infection (2.0 log10 PRNT, P=0.052). The early serum neutralizing response to secondary infection (3.02 log10 PRNT) was significantly greater than the early primary response (1.9 log10 PRNT, P<0.0001). Variation in population-level virus transmission corresponded with changes in the mean cohort-level neutralizing titers. It is concluded that following primary RSV infection the neutralizing antibody response declines to pre-infection levels rapidly (~3 months) which may facilitate repeat infection. The kinetics of the aggregate levels of acquired antibody reflect seasonal RSV occurrence, age, and infection history.
authors: Kenya Medical Research Institute (KEMRI), Centre for Geographic Medicine Research (Coast), Kilifi, Kenya. csande@kilifi.kemri-wellcome.org
authors: C J
authors: CJ
authors: Sande
authors: M N
authors: MN
authors: Mutunga
authors: E A
authors: EA
authors: Okiro
authors: G F
authors: GF
authors: Medley
authors: P A
authors: PA
authors: Cane
authors: D J
authors: DJ
authors: Nokes
mesh_terms: D057134:Antibodies, Neutralizing / Q000097:blood*; D000914:Antibodies, Viral / Q000097:blood*; D015331:Cohort Studies; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007630:Kenya / Q000453:epidemiology; D009500:Neutralization Tests; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000276:immunology*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology*; D012424:Rural Population; D010948:Viral Plaque Assay
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral
keywords: RSV; immunity; neutralizing antibody dynamics
references: Pediatr Infect Dis J. 2008 Mar;27(3):207-12
references: 18277934
references: J Pediatr. 1980 May;96(5):808-13
references: 7365579
references: N Engl J Med. 1976 Feb 19;294(8):414-9
references: 173995
references: BMC Infect Dis. 2010 Jan 22;10:15
references: 20096106
references: Clin Infect Dis. 2008 Jan 1;46(1):50-7
references: 18171213
references: Eur J Clin Microbiol. 1987 Apr;6(2):212
references: 3595584
references: J Infect Dis. 1991 Apr;163(4):693-8
references: 2010624
references: Am J Epidemiol. 2012 Nov 1;176(9):794-802
references: 23059788
references: Vaccine. 2003 Jul 28;21(24):3479-82
references: 12850364
references: J Infect Dis. 2012 Nov 15;206(10):1532-41
references: 22966119
references: N Engl J Med. 1979 Mar 8;300(10):530-4
references: 763253
references: Vaccine. 2007 Dec 21;26(1):59-66
references: 18063236
references: Pediatrics. 2002 Aug;110(2 Pt 1):e20
references: 12165619
references: Clin Infect Dis. 2009 Nov 1;49(9):1341-9
references: 19788358
references: J Pediatr. 2009 Feb;154(2):296-8
references: 19150677
references: J Infect Dis. 2004 Nov 15;190(10):1828-32
references: 15499540
references: J Clin Microbiol. 1986 Jun;23(6):1009-14
references: 3754878
references: J Infect Dis. 2013 Feb 1;207(3):489-92
references: 23175761
references: Lancet. 2010 May 1;375(9725):1545-55
references: 20399493
references: Antiviral Res. 2004 Sep;63(3):191-6
references: 15451187
references: PLoS One. 2009 Dec 02;4(12):e8088
references: 19956576
references: J Pediatr. 1981 May;98(5):708-15
references: 7229749